Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers

被引:3
|
作者
Wang, Xuezhu [1 ,2 ]
Dong, Yucheng [1 ,2 ]
Wu, Zilong [3 ]
Wang, Guanqun [4 ]
Shi, Yue [1 ,2 ]
Zheng, Yongchang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, CAMS & PUMC, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll PUMC, CAMS & PUMC, Beijing, Peoples R China
[3] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Hepatobiliary Surg, Affiliated Hosp 1, Changsha, Peoples R China
[4] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Ctr Synthet & Syst Biol, Sch Life Sci,Minist Educ,Key Lab Bioinformat, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
pan-cancer; circRNA; plasma exosomal biomarkers; machine learning; cancer mutations; RNA; DATABASE; LANDSCAPE;
D O I
10.3389/fonc.2021.703461
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A growing body of evidence has shown that circular RNA (circRNA) is a promising exosomal cancer biomarker candidate. However, global circRNA alterations in cancer and the underlying mechanism, essential for identification of ideal circRNA cancer biomarkers, remain under investigation. We comparatively analyzed the circRNA landscape in pan-cancer and pan-normal tissues. Using co-expression and LASSO regularization analyses, as well as a support vector machine, we analyzed 265 pan-cancer and 319 pan-normal tissues in order to identify the circRNAs with the highest ability to distinguish between pan-cancer and pan-normal tissues. We further studied their expression in plasma exosomes from patients with cancer and their relation with cancer mutations and tumor microenvironment landscape. We discovered that circRNA expression was globally reduced in pan-cancer tissues and plasma exosomes from cancer patients than in pan-normal tissues and plasma exosomes from healthy controls. We identified dynein axonemal heavy chain 14 (DNAH14), the top back-spliced gene exclusive to pan-cancer tissues, as the host gene of three pan-cancer tissue-enriched circRNAs. Among these three circRNAs, chr1_224952669_224968874_+ was significantly elevated in plasma exosomes from hepatocellular carcinoma and colorectal cancer patients. It was also related to the cancer mutation chr1:224952669: G>A, a splice acceptor variant, and was increasingly transcription-driven in cancer tissues. Moreover, pan-cancer tissue-enriched and pan-normal tissue-enriched circRNAs were associated with distinct tumor microenvironment patterns. Our machine learning-based analysis provides insights into the aberrant landscape and biogenesis of circRNAs in cancer and highlights cancer mutation-related and DNAH14-derived circRNA, chr1_224952669_224968874_+, as a potential cancer biomarker.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] A pan-cancer analysis of synonymous mutations
    Yogita Sharma
    Milad Miladi
    Sandeep Dukare
    Karine Boulay
    Maiwen Caudron-Herger
    Matthias Groß
    Rolf Backofen
    Sven Diederichs
    [J]. Nature Communications, 10
  • [2] A pan-cancer analysis of synonymous mutations
    Sharma, Yogita
    Miladi, Milad
    Dukare, Sandeep
    Boulay, Karine
    Caudron-Herger, Maiwen
    Gross, Matthias
    Backofen, Rolf
    Diederichs, Sven
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
    Yongsheng Li
    Tiantongfei Jiang
    Weiwei Zhou
    Junyi Li
    Xinhui Li
    Qi Wang
    Xiaoyan Jin
    Jiaqi Yin
    Liuxin Chen
    Yunpeng Zhang
    Juan Xu
    Xia Li
    [J]. Nature Communications, 11
  • [4] Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
    Li, Yongsheng
    Jiang, Tiantongfei
    Zhou, Weiwei
    Li, Junyi
    Li, Xinhui
    Wang, Qi
    Jin, Xiaoyan
    Yin, Jiaqi
    Chen, Liuxin
    Zhang, Yunpeng
    Xu, Juan
    Li, Xia
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [5] Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
    Bi, Guoshu
    Bian, Yunyi
    Liang, Jiaqi
    Yin, Jiacheng
    Li, Runmei
    Zhao, Mengnan
    Huang, Yiwei
    Lu, Tao
    Zhan, Cheng
    Fan, Hong
    Wang, Qun
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [6] Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
    Guoshu Bi
    Yunyi Bian
    Jiaqi Liang
    Jiacheng Yin
    Runmei Li
    Mengnan Zhao
    Yiwei Huang
    Tao Lu
    Cheng Zhan
    Hong Fan
    Qun Wang
    [J]. Journal of Translational Medicine, 19
  • [7] Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
    Ding, Wubin
    Chen, Geng
    Shi, Tieliu
    [J]. EPIGENETICS, 2019, 14 (01) : 67 - 80
  • [8] PAN-cancer analysis of S-phase enriched IncRNAs identifies oncogenic drivers and biomarkers
    Ali, Mohamad Moustafa
    Akhade, Vijay Suresh
    Kosalai, Subazini Thankaswamy
    Subhash, Santhilal
    Statello, Luisa
    Meryet-Figuiere, Matthieu
    Abrahamsson, Jonas
    Mondal, Tanmoy
    Kanduri, Chandrasekhar
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [9] PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
    Mohamad Moustafa Ali
    Vijay Suresh Akhade
    Subazini Thankaswamy Kosalai
    Santhilal Subhash
    Luisa Statello
    Matthieu Meryet-Figuiere
    Jonas Abrahamsson
    Tanmoy Mondal
    Chandrasekhar Kanduri
    [J]. Nature Communications, 9
  • [10] Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome
    Izzi, Valerio
    Davis, Martin N.
    Naba, Alexandra
    [J]. CANCERS, 2020, 12 (08) : 1 - 21